Related Experiment Video

Updated: Jun 26, 2026

Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders
05:34

Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders

Published on: August 18, 2023

[Chronic obstructive pulmonary disease and cardiovascular system]

Alev Gürgün1, Cemil Gürgün

  • 1Department of Chest Diseases, Faculty of Medicine, Ege University, Izmir, Turkey. alev.gurgun@ege.edu.tr

Tuberkuloz Ve Toraks
|January 6, 2009
PubMed

Insights

Chronic obstructive pulmonary disease (COPD) significantly increases cardiovascular disease (CVD) risk. Systemic inflammation is a key link, and treatments like inhaled corticosteroids and statins may improve outcomes for both conditions.

Area of Science:

  • Pulmonology
  • Cardiology
  • Inflammation Research

Context:

  • Chronic obstructive pulmonary disease (COPD) is a major global health burden, causing millions of deaths annually and projected to increase.
  • COPD patients face higher risks of cardiovascular diseases (CVD), lung cancer, osteoporosis, and muscle wasting.

Purpose:

  • To review the intricate relationship between COPD and cardiovascular diseases, focusing on atherosclerosis.
  • To explore common pathogenetic mechanisms, the impact of comorbidities on pulmonary function and mortality, and treatment strategies.

Summary:

  • Systemic inflammation is identified as a crucial common etiological factor linking COPD and CVD.
  • The review discusses the role of medications, including inhaled corticosteroids and statins, in managing both pulmonary and systemic inflammation and their effects on cardiovascular endpoints and mortality.
  • Investigates the influence of cardiovascular comorbidities on COPD prognosis and mortality prediction.

Impact:

  • Highlights potential therapeutic strategies targeting inflammation for improved cardiovascular outcomes in COPD patients.
  • Provides a new perspective on managing COPD by considering its cardiovascular implications and the benefits of anti-inflammatory treatments.
  • Emphasizes the need for integrated management of COPD and associated cardiovascular conditions to reduce morbidity and mortality.

More Related Videos

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

Related Concept Videos

Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...